Longitudinal pathways of exclusive and polytobacco cigarette use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).
Adolescent
Adult
Age Factors
Child
Cigarette Smoking
/ epidemiology
Cohort Studies
Cross-Sectional Studies
Humans
Longitudinal Studies
Prevalence
Smokers
/ statistics & numerical data
Time Factors
Tobacco Products
/ statistics & numerical data
Tobacco Use
/ epidemiology
United States
/ epidemiology
Young Adult
non-cigarette tobacco products
prevention
surveillance and monitoring
Journal
Tobacco control
ISSN: 1468-3318
Titre abrégé: Tob Control
Pays: England
ID NLM: 9209612
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
15
01
2020
revised:
22
01
2020
accepted:
27
01
2020
entrez:
24
4
2020
pubmed:
24
4
2020
medline:
3
6
2021
Statut:
ppublish
Résumé
Cigarettes are the most harmful and most prevalent tobacco product in the USA. This study examines cross-sectional prevalence and longitudinal pathways of cigarette use among US youth (12-17 years), young adults (18-24 years) and adults 25+ (25 years and older). Data were drawn from the first three waves (2013-2016) of the Population Assessment of Tobacco and Health Study, a nationally representative, longitudinal cohort study of US adults and youth. Respondents with data at all three waves (youth, N=11 046; young adults, N=6478; adults 25+, N=17 188) were included in longitudinal analyses. Among Wave 1 (W1) any past 30-day (P30D) cigarette users, more than 60%, persistently used cigarettes across three waves in all age groups. Exclusive cigarette use was more common among adult 25+ W1 P30D cigarette users (62.6%), while cigarette polytobacco use was more common among youth (57.1%) and young adults (65.2%). Persistent exclusive cigarette use was the most common pathway among adults 25+ and young adults; transitioning from exclusive cigarette use to cigarette polytobacco use was most common among youth W1 exclusive cigarette users. For W1 youth and young adult cigarette polytobacco users, the most common pattern of use was persistent cigarette polytobacco use. Cigarette use remains persistent across time, regardless of age, with most W1 P30D smokers continuing to smoke at all three waves. Policy efforts need to continue focusing on cigarettes, in addition to products such as electronic nicotine delivery systems that are becoming more prevalent.
Identifiants
pubmed: 32321847
pii: tobaccocontrol-2020-055630
doi: 10.1136/tobaccocontrol-2020-055630
pmc: PMC7553144
mid: NIHMS1604094
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
s139-s146Subventions
Organisme : NIDA NIH HHS
ID : HHSN271201100027C
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: WMC reports long-term stock holdings in General Electric Company, 3M Company, and Pfizer Incorporated, unrelated to this manuscript. No financial disclosures were reported by the other authors of this paper.
Références
Am J Prev Med. 2017 Jul;53(1):e1-e7
pubmed: 28094133
Prev Med. 2014 May;62:14-9
pubmed: 24440684
MMWR Morb Mortal Wkly Rep. 2017 Jun 16;66(23):597-603
pubmed: 28617771
Tob Control. 2020 May;29(Suppl 3):s155-s162
pubmed: 32321849
Tob Control. 2011 Sep;20(5):388-90
pubmed: 21330318
Tob Control. 2016 Mar;25(2):174-80
pubmed: 25361744
Nicotine Tob Res. 2008 Nov;10(11):1581-9
pubmed: 18988070
Prev Chronic Dis. 2016 Jan 14;13:E08
pubmed: 26766849
Addict Behav. 2014 Jan;39(1):101-6
pubmed: 24172753
Am J Health Behav. 2017 Jan;41(1):84-91
pubmed: 27935794
Addict Behav. 2007 Oct;32(10):2411-9
pubmed: 17490825
Nicotine Tob Res. 2004 Aug;6(4):621-9
pubmed: 15370158
MMWR Morb Mortal Wkly Rep. 2016 Aug 05;65(30):753-8
pubmed: 27491017
Tob Control. 2020 May;29(Suppl 3):s216-s226
pubmed: 32321855
Tob Control. 2020 May;29(Suppl 3):s178-s190
pubmed: 32321852
Drug Alcohol Depend. 2016 May 1;162:92-8
pubmed: 26987520
Addict Behav. 2013 Jul;38(7):2267-72
pubmed: 23583831
Tob Control. 2020 May;29(Suppl 3):s163-s169
pubmed: 32321850
Am J Prev Med. 2014 Aug;47(2 Suppl 1):S87-9
pubmed: 25044200
LGBT Health. 2017 Feb;4(1):24-33
pubmed: 28068208
Vital Health Stat 2. 1969 Jan;(31):1-24
pubmed: 5306564
Nicotine Tob Res. 2016 Jul;18(7):1596-605
pubmed: 26764258
Am J Drug Alcohol Abuse. 2017 Nov;43(6):694-702
pubmed: 27668320
MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1205-1211
pubmed: 27832052
PLoS One. 2017 Feb 9;12(2):e0171808
pubmed: 28182748
Int J Environ Res Public Health. 2011 Oct;8(10):3871-88
pubmed: 22073018
Tob Control. 2019 Nov;28(6):663-668
pubmed: 30297373
Tob Control. 2017 Jul;26(4):371-378
pubmed: 27507901
Tob Control. 2020 May;29(Suppl 3):s191-s202
pubmed: 32321853
Pediatrics. 2015 Mar;135(3):409-15
pubmed: 25647680
Nicotine Tob Res. 2010 Oct;12 Suppl:S20-33
pubmed: 20889477
Tob Control. 2020 May;29(Suppl 3):s203-s215
pubmed: 32321854
Nicotine Tob Res. 2016 Feb;18(2):156-62
pubmed: 25744961
N Engl J Med. 2017 Jan 26;376(4):342-353
pubmed: 28121512
Tob Control. 2020 May;29(Suppl 3):s170-s177
pubmed: 32321851
Tob Control. 2020 May;29(Suppl 3):s147-s154
pubmed: 32321848
Drug Alcohol Depend. 2017 Sep 1;178:257-266
pubmed: 28675817
Am J Public Health. 2000 Mar;90(3):387-94
pubmed: 10705856
J Adolesc Health. 2003 Dec;33(6):436-57
pubmed: 14642706